USADA announced today that Trey Lampkin, of Toledo, Ohio, an athlete in the sport of Paralympic judo, has accepted a public warning for failing to obtain a Therapeutic Use Exemption (TUE) prior to his use of an otherwise prohibited medication. Lampkin’s violation resulted from his use of hydrochlorothiazide (HCTZ), a prescription medication that he used under the care of a physician for a diagnosed medical condition. Lampkin, 31, has discontinued use of the prohibited medication, so no TUE is required.
Because Lampkin’s positive sample from June 15, 2021 was collected out of competition, there are also no competitive results to disqualify.
In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, a nutrition guide, an athlete handbook, and periodic alerts and advisories.
USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by text at 87232, by email at email@example.com, by phone at 1-877-Play Clean (1-877-752-9253), or by mail.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.